MDT - Medtronic: Dividend Aristocrat Value In Plain Sight

2024-04-13 08:15:00 ET

Summary

• Medtronic is a healthcare technology company that has seen encouraging growth in the current fiscal year.
• The company has maintained pricing power and has a strong balance sheet, with an A+ grade for profitability.
• Medtronic is well-positioned for future opportunities, including diabetes care, and is undervalued compared to historical norms with a decent starting dividend yield.

Buying quality companies at reasonable prices remains a winning investment strategy in my opinion despite all the noise around high-flying Al names on the market today. What's even better is if those stocks pay you a decent yield for holding onto them, which makes natural price volatility easier to bear....

For further details see: